Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017-2021
Abstract Introduction Due to concerns over potential interactions between some hepatitis C direct-acting antivirals (DAAs) and opioids, we describe adverse event (AE) reports of concomitant use of opioids and DAAs. Methods AEs reported (July 28, 2017-December 31, 2021) with the administration of the...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Book |
Published: |
BMC,
2023-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
Call Number: |
A1234.567 |
---|---|
Copy 1 | Available |